Accès gratuit
Med Sci (Paris)
Volume 29, Mars 2013
Page(s) 19 - 24
Section M/S Revues
Publié en ligne 13 mars 2013
  1. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 2012 ; 54 (suppl 1) : S35–S43. [CrossRef] [PubMed] [Google Scholar]
  2. Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology, clinical manifestations of mucormycosis. Clin Infect Dis 2012 ; 54 (suppl 1) : S23–S34. [CrossRef] [PubMed] [Google Scholar]
  3. Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis 2012 ; 54 (suppl 1) : S44–S54. [CrossRef] [PubMed] [Google Scholar]
  4. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 ; 41 : 634–653. [CrossRef] [PubMed] [Google Scholar]
  5. Ruping MJ, Heinz WJ, Kindo AJ, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother 2010 ; 65 : 296–302. [CrossRef] [PubMed] [Google Scholar]
  6. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect 2011 ; 17 : 1859–1867. [CrossRef] [PubMed] [Google Scholar]
  7. Skiada A, Lanternier F, Groll AH, et al. Diagnosis and treatment of mucormycosis in patients with haematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2012 ; 14 septembre (online). [PubMed] [Google Scholar]
  8. Bouchara JP, Oumeziane NA, Lissitzky JC, et al. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol 1996 ; 70 : 76–83. [PubMed] [Google Scholar]
  9. Chamilos G, Lewis RE, Lamaris G, et al. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother 2008 ; 52 : 722–724. [CrossRef] [PubMed] [Google Scholar]
  10. Chamilos G, Lewis RE, Hu J, et al. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci USA 2008 ; 105 : 9367–9372. [CrossRef] [Google Scholar]
  11. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994 ; 19 : 67–76. [CrossRef] [PubMed] [Google Scholar]
  12. Antoniadou A. Outbreaks of zygomycosis in hospitals. Clin Microbiol Infect 2009 ; 15 (suppl 5) : 55–59. [CrossRef] [PubMed] [Google Scholar]
  13. Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg 1991 ; 78 : 952–954. [CrossRef] [PubMed] [Google Scholar]
  14. Tournas VH. Spoilage of vegetable crops by bacteria and fungi and related health hazards. Crit Rev Microbiol 2005 ; 31 : 33–44. [CrossRef] [PubMed] [Google Scholar]
  15. Cheng VC, Chan JF, Ngan AH, et al. Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 2009 ; 47 : 2834–2843. [CrossRef] [PubMed] [Google Scholar]
  16. Verma A, Brozman B, Petito CK. Isolated cerebral mucormycosis: report of a case and review of the literature. J Neurol Sci 2006 ; 240 : 65–69. [CrossRef] [PubMed] [Google Scholar]
  17. Artis WM, Fountain JA, Delcher HK, Jones HE. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982 ; 31 : 1109–1114. [CrossRef] [PubMed] [Google Scholar]
  18. Sun HY, Singh N. Mucormycosis: its contemporary face and management strategies. Lancet Infect Dis 2011 ; 11 : 301–311. [CrossRef] [PubMed] [Google Scholar]
  19. Xhaard A, Lanternier F, Porcher R, et al. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003–2008). Clin Microbiol Infect 2012 ; 18 : E396–E400. [CrossRef] [PubMed] [Google Scholar]
  20. Chamilos G, Marom EM, Lewis RE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005 ; 41 : 60–66. [CrossRef] [PubMed] [Google Scholar]
  21. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 2009 ; 15 : 1395–1401. [CrossRef] [PubMed] [Google Scholar]
  22. Phai Pang KA, Godet C, Fekkar A, et al. Breakthrough invasive mould infections in patients treated with caspofungin. J Infect 2012 ; 64 : 424–429. [CrossRef] [PubMed] [Google Scholar]
  23. Suzuki K, Sugawara Y, Sekine T, et al. Breakthrough disseminated zygomycosis induced massive gastrointestinal bleeding in a patient with acute myeloid leukemia receiving micafungin. J Infect Chemother 2009 ; 15 : 42–45. [CrossRef] [PubMed] [Google Scholar]
  24. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994 ; 39 : 3–22. [CrossRef] [PubMed] [Google Scholar]
  25. Rothstein RD, Simon GL. Subacute pulmonary mucormycosis. J Med Vet Mycol 1986 ; 24 : 391–394. [CrossRef] [PubMed] [Google Scholar]
  26. Marchiori E, Zanetti G, Meirelles GS, et al. The reversed halo sign on high-resolution CT in infectious and noninfectious pulmonary diseases. AJR Am J Roentgenol 2011 ; 197 : W69–W75. [CrossRef] [PubMed] [Google Scholar]
  27. Cooter RD, Lim IS, Ellis DH, Leitch IO. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990 ; 28 : 2151–2153. [PubMed] [Google Scholar]
  28. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009 ; 15 (suppl 5) : 41–45. [CrossRef] [Google Scholar]
  29. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995 ; 20 : 617–620. [CrossRef] [PubMed] [Google Scholar]
  30. Mooney JE, Wanger A. Mucormycosis of the gastrointestinal tract in children: report of a case and review of the literature. Pediatr Infect Dis J 1993 ; 12 : 872–876. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.